ODDB.org: Open Drug Database | Medikamente

Home - FI zu ADYNOVI

Fachinformation zu ADYNOVI:

Takeda Pharma AG

B02BD02 - Coagulation Factor Viii

ATC-DDD Version 2016. Source: WHO

B - Blood and Blood Forming Organs

B02 - Antihemorrhagics

B02B - Vitamin K and Other Hemostatics

The DDDs are based on treatment of hemorrhage associated with different deficiency states (e.g. vitamin K deficiency, deficiency of different blood coagulation factors etc.).

B02BD - Blood Coagulation Factors

This group comprises all blood coagulation factors, thrombin etc., incl. preparations for local use, and their combinations. Gene therapy products replacing coagulation factors are also classified in this group.
For systemic formulations of fibrinogen (factor I), see - B02BB - Fibrinogen.
Prothrombin complexes containg three or all four factors are classified in B02BD01 coagulation factor IX, II, VII and X.
Both human derived and recombinant factor VIII and factor IX products will be classified in B02BD02 - coagulation factor VIII and B02BD04 - coagulation factor IX, respectively.

No DDDs are established for blood coagulation factors. The use of blood coagulation factors could be measured in blood factor units (IU).

B02BD02 - Coagulation Factor Viii

2024	©ywesee GmbH